GZMB and atherosclerosis: Finally, the proteinase inhibitor-9, the GrB endogenous inhibitor, was reduced in unstable atherosclerotic lesions compared to stable lesions (44), according to the hypothesis of a role for GrB in plaque instability and suggesting that GrB activity in atherosclerosis may be regulated by an imbalance between GrB and its inhibitor.